BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1194986)

  • 41. Detection of diffuse glomerular lesions in rats: I. Comparisons of conventional radioactive agents.
    McAfee JG; Thomas FD; Subramanian G; Lyons B; Roskopf M
    J Nucl Med; 1986 Apr; 27(4):502-12. PubMed ID: 3012028
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 169 Ytterbium diethylenetriaminepentaacetic acid ( 169 YB DTPA)--a versatile radiopharmaceutical.
    James AE; Hosain F; DeLand FH; Reba RC; Wagner HN
    J Can Assoc Radiol; 1971 Jun; 22(2):136-43. PubMed ID: 5109313
    [No Abstract]   [Full Text] [Related]  

  • 43. [Proposal for the preparation and testing of the 99mTc-Sn-gluconate complex for renal scintigraphy. II. Simplified method].
    Charamza O
    Cesk Farm; 1975 Nov; 24(9):405. PubMed ID: 1218410
    [No Abstract]   [Full Text] [Related]  

  • 44. Renal cortical imaging in 35 patients: superior quality with 99mTc-DMSA.
    Enlander D; Weber PM; dos Remedios LV
    J Nucl Med; 1974 Sep; 15(9):743-9. PubMed ID: 4854105
    [No Abstract]   [Full Text] [Related]  

  • 45. Comparison of 99mTc-labelled hepatobiliary agents-- 99mTc-pyridoxylidene glutamate (99mTc-PG) and 99mTc-Sn-lidocaine iminodiacetic acid (99mTc-Sn-LIDA).
    Sewatkar AB; Noronha OP
    Nuklearmedizin; 1976 Dec; 15(6):290-3. PubMed ID: 1012924
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Technetium-99m-glucoheptonate as a brain-scanning agent: critical comparison with pertechnetate.
    Waxman AD; Tanacescu D; Siemsen JK; Wolfstein RS
    J Nucl Med; 1976 May; 17(5):345-8. PubMed ID: 1262934
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of the biodistribution of gadolinium-153 DTPA and technetium-99m DTPA in rats.
    Prato FS; Wisenberg G; Marshall TP; Uksik P; Zabel P
    J Nucl Med; 1988 Oct; 29(10):1683-7. PubMed ID: 3049959
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dissolution rate and transit times of technetium-99m DTPA-labeled tablets.
    Maublant JC; Sournac M; Aiache JM; Veyre A
    J Nucl Med; 1987 Jul; 28(7):1199-203. PubMed ID: 3298574
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Accumulation of 99mTc-glucoheptonate in acutely infarcted myocardium.
    Rossman DJ; Strauss HW; Siegel ME; Pitt B
    J Nucl Med; 1975 Oct; 16(10):875-8. PubMed ID: 1177016
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Radionuclide detection of a pheochromocytoma.
    Petrocelli RD; Wetzel RA
    J Nucl Med; 1975 Mar; 16(3):234-5. PubMed ID: 234525
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 99mTechnetium-unithiol complex, a new pharmaceutical for kidney scintigraphy.
    Ogiński M; Rembelska M
    Nuklearmedizin; 1976 Dec; 15(6):282-6. PubMed ID: 1012922
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemistry of 99mTc tracers. II. In vitro conversion of tagged HEDP and pyrophosphate (bone-seekers) into gluconate (renal agent). Effects of Ca and Fe (ii) on in vivo distribution.
    McRae J; Hambright P; Valk P; Bearden AJ
    J Nucl Med; 1976 Mar; 17(3):208-11. PubMed ID: 175138
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Organ distribution of 99mTc- and 51Cr-labeled autologous peripheral blood lymphocytes in rabbits.
    Gobuty AH; Robinson RG; Barth RF
    J Nucl Med; 1977 Feb; 18(2):141-6. PubMed ID: 833659
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Measurement of renal blood flow with the Anger scintillation camera after selective intra-arterial injections of 133xenon and 99mtechnetium].
    Heidenreich P; Hör G; Kempken K; Oberdorfer M; Kramann B; Fübetal H; Pabst HW
    Rofo; 1975 Jan; 122(1):63-73. PubMed ID: 122961
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative chemical, biological and clinical studies of 99mtc-glucoheptonate and 99mtc-dimercaptosuccinate as used in renal scintigraphy.
    Vanlić-Razumenić N; Malesević M; Stefanović L
    Nuklearmedizin; 1979 Feb; 18(1):40-5. PubMed ID: 219419
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of renal extraction efficiencies for radioactive agents in the normal dog.
    McAfee JG; Grossman ZD; Gagne G; Zens AL; Subramanian G; Thomas FD; Fernandez P; Roskopf ML
    J Nucl Med; 1981 Apr; 22(4):333-8. PubMed ID: 7205379
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Technetium-99m DADS complexes as renal function and imaging agents: II. Biological comparison with iodine-131 hippuran.
    McAfee JG; Subramanian G; Schneider RF; Roskopf M; Lyons B; Ritter C; Zapf-Longo C; Palladino E; Thomas FD
    J Nucl Med; 1985 Apr; 26(4):375-84. PubMed ID: 3981257
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Body-background defects with 99mTc-DTPA after renal transplantation: case reports.
    Corcoran RJ; Thrall JH; Kaminski RJ; Varma VM; Johnson MC
    J Nucl Med; 1976 Aug; 17(8):696-8. PubMed ID: 778351
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Patterns of excretion of radioactive chelates in obstructive uropathy.
    Kirchner PT; James AE; Reba RC; Wagner HN
    Radiology; 1975 Mar; 114(3):655-61. PubMed ID: 235149
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Instant 99mTc-labelled glucoheptonate kit for kidney imaging.
    Agha NH; Al-Hilli M; Karim HM; Al-Hissoni MH; Jassim MN
    Nuklearmedizin; 1983 Oct; 22(5):246-50. PubMed ID: 6657485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.